Articles tagged with: Stem Cell Transplant
During my 25-year career as a boy’s basketball head coach, I coached over 600 games.
Regardless of whether it was the 1983 Class A state championship game in my rookie year as a head coach (we lost), or games against opponents that we were overwhelming favorites to defeat, my state of mind the night before each one of those 600 plus games never changed.
That state of mind is difficult to describe. It was one of unbearable excitement, tempered by an actual feeling of fear. Fear that I had not …
Despite being a lifelong Boston Celtics fan, one of my favorite coaches is former Los Angeles Lakers coach Pat Riley.
I know that sounds traitorous to most Celtics fans, especially considering the fierceness of the teams’ rivalry in the early and mid 1980s: Bird versus Magic, Showtime versus Blue Collar, Kareem versus The Chief, McHale versus Worthy.
With all due respect to Lebron James, Kevin Durant, and the rest of the NBA today, those were the glory days of the NBA!
As a young coach during that time, I consumed …
Significant improvements in donor stem cell transplantation have been made in recent years. As a result, donor transplantation – a procedure during which a patient receives stem cells from a healthy donor – has become safer and typically more successful for patients.
The majority of patients undergoing donor stem cell transplantation receive stem cells from unrelated donors. In these cases, a close match between donor and recipient tissue types is known to play an important important role in transplant outcomes.
A group of German researchers last fall published results of …
A group of Spanish researchers published a summary last year of the patterns of relapse and progression they observed in multiple myeloma patients who underwent stem cell transplantation as part of their upfront therapy.
The researchers observed relapse in over half of the patients included in the study. Among these patients, the majority had only achieved a partial response after transplantation.
They also found that how a patient relapsed had an impact on their prognosis after relapse. Patients who relapsed based solely on changes in disease markers, such as their …
Results of several studies investigating Revlimid maintenance therapy for multiple myeloma will be presented at this year’s American Society of Hematology (ASH) annual meeting, which starts later this week.
Today’s article previews the results of the key Revlimid maintenance studies that will be presented at the meeting, drawing on findings published in the meeting abstracts. Some of the study results, it should be noted, will be updated during the presentations at ASH this week and early next week.
The results to be presented at ASH are unlikely to settle the …